InfuSystem Q2 2025: Net Revenues Up 7% to $36M, Net Income Surges 262% to $2.6M, EPS at $0.12
InfuSystem Holdings Inc. has announced its second quarter 2025 financial results, reporting record net revenues of $36.0 million, representing a 7% growth from the prior year. The company experienced a significant increase in net income, which rose to $2.6 million, a 262% increase compared to the previous year. Earnings per share were reported at $0.12 per diluted share, up from $0.03 per diluted share in the prior year. The company's adjusted EBITDA (non-GAAP) was $8.0 million, reflecting a 32% increase from the previous year, with the adjusted EBITDA margin expanding by 4.3% to 22.3%. Gross profit also saw a notable increase of 19%, amounting to $19.9 million, with a gross margin of 55.2%, an increase of 5.7% from the prior year. InfuSystem's net operating cash flow grew by 227% to $8.8 million. The company also reported stock repurchases totaling $3.5 million during the quarter, with total liquidity reaching $49.1 million as of June 30, 2025. In terms of guidance for the full year 2025, InfuSystem updated its net revenue growth estimate to be in the range of 6% to 8%, a revision from the prior range of 8% to 10%. The company also forecasts an adjusted EBITDA margin of 20% or higher, representing a 120 basis point increase over 2024.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InfuSystem Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-25-037582), on August 05, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.